This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Mechanisms

Authoring team

For a tumour to invade and infiltrate locally, its cells must acquire the ability to proliferate and advance into the extracellular matrix. Basement membranes are one of the first barriers that need to be traversed and this may be achieved by tumour cells:

  • binding to basement membrane laminin - provides a fixed point for cell movement
  • secreting their own laminin - provides a link to type IV collagen in basement membranes
  • binding adjacent fibronectin molecules

The dynamic interplay of interactions such as these ensures that the cell can fix onto a point in the direction that it is about to advance. However, a space must be created in which the cell can move: this is mainly achieved by degradation of the extracellular matrix. For example, human fibrosarcoma may utilise a type IV collagenase enzyme. A variety of other enzymes are also secreted, e.g. elastases and plasmin, to breakdown non-collagenous matrix. Cancer cells may also indirectly advance by stimulating host cells to secrete proteolytic enzymes.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.